Mirum Pharmaceuticals (MIRM) Financials: History & Chart

Compare

Mirum Pharmaceuticals, Inc.(MIRM)

Biotechnology · Foster City, CA

$79.41-2.03 (-2.49%)

Delayed quote: Oct 6, 2026, 12:50 PM EDT

Compare

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	618.07M	176.24M	159.88M	148.93M	133.01M	127.78M	111.58M	99.41M	90.38M
Cost of Goods Sold	113.10M	30.35M	28.88M	28.34M	25.54M	23.42M	23.02M	22.78M	20.81M
Gross Profit	504.96M	145.90M	131.00M	120.59M	107.47M	104.36M	88.57M	76.63M	69.57M
Gross Profit Margin	81.7%	82.8%	81.9%	81.0%	80.8%	81.7%	79.4%	77.1%	77.0%
Total Operating Expenses	612.78M	188.43M	194.24M	125.23M	104.87M	109.35M	103.75M	100.86M	82.25M
Research & Development	282.50M	90.53M	97.91M	51.11M	42.96M	46.07M	46.04M	44.03M	31.71M
Selling, General & Administrative	313.84M	81.47M	96.33M	74.13M	61.91M	63.29M	57.71M	56.83M	50.55M
Operating Income (EBIT)	-107.66M	-42.54M	-63.16M	-4.57M	2.60M	-4.99M	-15.18M	-24.22M	-12.68M
Operating Margin	-17.4%	-24.1%	-39.5%	-3.1%	2.0%	-3.9%	-13.6%	-24.4%	-14.0%
Income Before Tax (EBT)	-857.54M	-65.54M	-789.68M	-4.96M	2.64M	-5.46M	-13.65M	-24.37M	-13.89M
Interest Income	13.92M	3.85M	3.40M	3.42M	3.25M	3.03M	3.02M	3.20M	3.47M
Interest Expense	13.44M	2.62M	3.62M	3.60M	3.61M	3.59M	3.60M	3.58M	3.59M
Other Income/Expense	-749.87M	-23.00M	-726.52M	-396K	40K	-470K	1.53M	-144K	-1.20M
Net Income	-860.21M	-67.23M	-790.15M	-5.73M	2.90M	-5.86M	-14.68M	-23.79M	-14.23M
Income Tax Expense	2.67M	1.69M	475K	767K	-262K	402K	1.03M	-576K	347K
Net Profit Margin	-139.2%	-38.1%	-494.2%	-3.8%	2.2%	-4.6%	-13.2%	-23.9%	-15.8%
EBITDA	-81.72M	-35.60M	-56.29M	1.51M	8.66M	1.07M	-9.13M	-18.17M	-6.63M
EBITDA Margin	-13.2%	-20.2%	-35.2%	1.0%	6.5%	0.8%	-8.2%	-18.3%	-7.3%
Depreciation & Amortization	25.95M	6.94M	6.87M	6.07M	6.06M	6.06M	6.05M	6.06M	6.05M
EPS Basic	-14.56	-1.06	-13.43	-0.12	0.05	-0.12	-0.30	-0.49	-0.30
EPS Diluted	-14.56	-1.06	-13.43	-0.12	0.05	-0.12	-0.30	-0.49	-0.30
Weighted Average Basic Shares	63.37M	63.37M	58.85M	50.20M	56.99M	49.73M	48.89M	48.34M	47.78M
Weighted Average Diluted Shares	63.37M	63.37M	58.85M	50.20M	56.99M	49.73M	48.89M	48.34M	47.78M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	521.31M	336.89M	186.37M	77.06M	19.14M	0.00	0.00	0.00
Cost of Goods Sold	100.58M	81.64M	47.04M	12.37M	1.90M	623K	324K	0.00
Gross Profit	420.73M	255.25M	139.34M	64.69M	17.23M	-623K	-324K	0.00
Gross Profit Margin	80.7%	75.8%	74.8%	83.9%	90.1%	N/A	N/A	N/A
Total Operating Expenses	443.21M	342.85M	248.49M	195.91M	190.65M	103.67M	54.74M	2.92M
Research & Development	186.18M	140.63M	102.61M	106.84M	131.43M	81.61M	42.99M	2.33M
Selling, General & Administrative	257.03M	202.22M	145.88M	89.07M	59.22M	22.69M	11.75M	585K
Operating Income (EBIT)	-22.14M	-87.61M	-109.15M	-131.22M	-173.41M	-104.30M	-54.74M	-2.92M
Operating Margin	-4.2%	-26.0%	-58.6%	-170.3%	-906.1%	N/A	N/A	N/A
Income Before Tax (EBT)	-21.43M	-86.91M	-162.42M	-142.07M	-83.95M	-103.26M	-52.53M	-17.35M
Interest Income	12.73M	13.79M	13.73M	3.86M	366K	1.56M	2.23M	87K
Interest Expense	14.39M	14.31M	15.11M	15.98M	17.59M	335K	N/A	N/A
Other Income/Expense	709K	694K	-53.27M	-10.85M	89.46M	1.03M	2.21M	-14.43M
Net Income	-23.36M	-87.94M	-163.41M	-135.66M	-83.99M	-103.27M	-52.55M	-17.35M
Income Tax Expense	1.94M	1.03M	991K	-6.41M	37K	6K	21K	0.00
Net Profit Margin	-4.5%	-26.1%	-87.7%	-176.0%	-438.9%	N/A	N/A	N/A
EBITDA	2.11M	-63.98M	-98.33M	-127.98M	-172.44M	-103.67M	-54.42M	1.46M
EBITDA Margin	0.4%	-19.0%	-52.8%	-166.1%	-901.0%	N/A	N/A	N/A
Depreciation & Amortization	24.24M	23.63M	10.83M	3.24M	975K	623K	324K	4.37M
EPS Basic	-0.47	-1.85	-4.00	-4.01	-2.77	-4.09	-2.29	-0.75
EPS Diluted	-0.47	-1.85	-4.00	-4.02	-2.77	-4.09	-2.29	-0.75
Weighted Average Basic Shares	50.20M	47.52M	40.89M	33.84M	30.32M	25.25M	22.99M	22.99M
Weighted Average Diluted Shares	50.20M	47.52M	40.89M	33.98M	30.32M	25.25M	22.99M	22.99M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.